GLP-1s are driving returns on R&D investments for Big Pharma, report says / Novo Nordisk, Eli Lilly and the GLP-1 economy / JPMorgan says this new player in the GLP-1 market could rally 45% / P&G stock deserves to be down after a messy quarter -- but not by this much / Eli Lilly's big GLP-1 investment -- plus, what we want from 4 portfolio stock earnings / JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%